BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.229
-0.039 (-14.59%)
At close: Dec 20, 2024, 4:00 PM
0.220
-0.009 (-3.89%)
After-hours: Dec 20, 2024, 5:44 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $4.11 million as of December 20, 2024. Its market cap has decreased by -70.50% in one year.
Market Cap
4.11M
Enterprise Value
220.72K
1-Year Change
-70.50%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $4.11M, a decrease of -90.24%. That is a compound annual growth rate of -42.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 4.11M | -56.08% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Marine Exploration | 7.83M |
| Danimer Scientific | 7.67M |
| Gulf Resources | 6.55M |
| Graphex Group | 6.50M |
| Bon Natural Life | 5.77M |
| SenesTech | 3.11M |
| IT Tech Packaging | 2.06M |
| N2OFF | 1.99M |